Does AXICABTAGENE CILOLEUCEL Cause Diffuse large b-cell lymphoma refractory? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Diffuse large b-cell lymphoma refractory have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 0.3% of all adverse event reports for AXICABTAGENE CILOLEUCEL.
23
Reports of Diffuse large b-cell lymphoma refractory with AXICABTAGENE CILOLEUCEL
0.3%
of all AXICABTAGENE CILOLEUCEL reports
7
Deaths
7
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From AXICABTAGENE CILOLEUCEL?
Of the 23 reports, 7 (30.4%) resulted in death, 7 (30.4%) required hospitalization, and 5 (21.7%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXICABTAGENE CILOLEUCEL. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?
Cytokine release syndrome (4,140)
Immune effector cell-associated neurotoxicity syndrome (1,821)
Neurotoxicity (1,327)
Pyrexia (859)
Death (756)
Disease progression (745)
Hypotension (398)
Neutropenia (391)
Confusional state (299)
Encephalopathy (292)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
AXICABTAGENE CILOLEUCEL vs AXITINIB
AXICABTAGENE CILOLEUCEL vs AZACITIDINE
AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE
AXICABTAGENE CILOLEUCEL vs AZD-1222
AXICABTAGENE CILOLEUCEL vs AZELAIC ACID